Tempus AI, Inc. (NASDAQ:TEM) CEO Eric P. Lefkofsky Sells 187,655 Shares

Tempus AI, Inc. (NASDAQ:TEM) CEO Eric P. Lefkofsky sold 187,655 shares of Tempus AI stock in a transaction dated Wednesday, December 18th. The stock was sold at an average price of $37.54, for a total value of $7,044,568.70. Following the completion of the transaction, the chief executive officer now owns 9,557,283 shares of the company’s stock, valued at approximately $358,780,403.82. This represents a 1.93 % decrease in their position. The transaction was disclosed in a filing with the SEC, which can be accessed through this hyperlink.

Tempus AI Trading Up 7.6 %

Shares of NASDAQ TEM opened at $35.54 on Friday. The company has a 50 day moving average price of $51.70. Tempus AI, Inc. has a 52-week low of $22.89 and a 52-week high of $79.49. The company has a quick ratio of 2.55, a current ratio of 2.69 and a debt-to-equity ratio of 8.17.

Analysts Set New Price Targets

Several research firms have recently weighed in on TEM. Piper Sandler reissued a “neutral” rating and set a $70.00 target price (up previously from $40.00) on shares of Tempus AI in a research report on Tuesday, November 12th. Wolfe Research started coverage on shares of Tempus AI in a research report on Friday, December 13th. They set an “outperform” rating and a $60.00 price objective on the stock. Bank of America increased their target price on shares of Tempus AI from $52.00 to $54.00 and gave the company a “neutral” rating in a research note on Friday, December 13th. Guggenheim began coverage on shares of Tempus AI in a report on Monday, December 9th. They set a “buy” rating and a $74.00 price target on the stock. Finally, Loop Capital increased their price objective on shares of Tempus AI from $48.00 to $57.00 and gave the stock a “buy” rating in a research report on Tuesday, October 15th. Three analysts have rated the stock with a hold rating and nine have issued a buy rating to the stock. Based on data from MarketBeat, the company has a consensus rating of “Moderate Buy” and a consensus target price of $56.00.

Institutional Investors Weigh In On Tempus AI

Several hedge funds have recently made changes to their positions in TEM. First Horizon Advisors Inc. bought a new position in shares of Tempus AI during the third quarter valued at approximately $30,000. Vestor Capital LLC purchased a new stake in Tempus AI during the third quarter worth $153,000. Stifel Financial Corp purchased a new stake in Tempus AI during the third quarter worth $218,000. Sandia Investment Management LP purchased a new position in shares of Tempus AI in the 2nd quarter valued at $136,000. Finally, IQ EQ FUND MANAGEMENT IRELAND Ltd purchased a new position in shares of Tempus AI in the 3rd quarter valued at $258,000. 24.22% of the stock is currently owned by hedge funds and other institutional investors.

Tempus AI Company Profile

Tempus AI Inc is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare. The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics.